ElringKlinger AG (ETR:ZIL2) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Investors in ElringKlinger AG (ETR:ZIL2) had a good week, as its shares rose 8.3% to close at €5.73 following the release of its third-quarter results. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on ElringKlinger after the latest results.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

After the latest results, the three analysts covering ElringKlinger are now predicting revenues of €1.82b in 2027. If met, this would reflect a modest 2.7% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to bounce 110% to €1.15. Before this earnings report, the analysts had been forecasting revenues of €1.81b and earnings per share (EPS) of €1.05 in 2027. The analysts seems to have become more bullish on the business, judging by their new earnings per share estimates.

View our latest analysis for ElringKlinger

There's been no major changes to the consensus price target of €5.40, suggesting that the improved earnings per share outlook is not enough to have a long-term positive impact on the stock's valuation. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. The most optimistic ElringKlinger analyst has a price target of €6.00 per share, while the most pessimistic values it at €4.80. The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects.

Of course, another way to look at these forecasts is to place them into context against the industry itself. The analysts are definitely expecting ElringKlinger's growth to accelerate, with the forecast 2.2% annualised growth to the end of 2027 ranking favourably alongside historical growth of 0.07% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 0.9% annually. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect ElringKlinger to grow faster than the wider industry.

The Bottom Line

The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around ElringKlinger's earnings potential next year. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. The consensus price target held steady at €5.40, with the latest estimates not enough to have an impact on their price targets.

With that in mind, we wouldn't be too quick to come to a conclusion on ElringKlinger. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for ElringKlinger going out to 2028, and you can see them free on our platform here..

Don't forget that there may still be risks. For instance, we've identified 3 warning signs for ElringKlinger that you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.